Articles

Buprenorphine in Primary Care at TTC means integrating medication, behavioral health services, and ongoing medical care to help patients overcome treatment barriers and begin recovery sooner.

For people living with opioid use disorder (OUD), timely access to treatment can save lives. Fortunately, recovery does not always need to begin in a specialized addiction treatment facility. Buprenorphine treatment in primary care offers a practical, evidence-based approach that makes addiction treatment more accessible.

By combining medication with behavioral health services and ongoing medical support, healthcare providers can reduce treatment barriers. This integrated approach also helps patients address their physical and emotional health while building a foundation for lasting recovery.

How Does Buprenorphine Treatment in Primary Care Work?

Buprenorphine is an FDA-approved medication that reduces opioid cravings and withdrawal symptoms. As a partial opioid agonist, it acts on the brain’s opioid receptors without producing the same effects as full opioid agonists such as heroin or fentanyl.

When appropriately prescribed, buprenorphine helps stabilize patients and supports continued participation in treatment. It also reduces the risk of opioid-related overdose and death.

The Substance Abuse and Mental Health Services Administration (SAMHSA) explains that these medications “relieve withdrawal symptoms and psychological cravings, reduce risk of overdose, and help patient retention in treatment.”

Such benefits make buprenorphine treatment in primary care an important option for people who might otherwise delay seeking help. Medication can also support long-term recovery when paired with appropriate medical monitoring and additional services.

Why Is Buprenorphine Treatment in Primary Care Important?

Access to addiction treatment can be challenging. Patients may face long wait times, transportation challenges, financial concerns, or stigma associated with specialized treatment facilities.

Buprenorphine treatment in primary care can help overcome these obstacles by integrating addiction services into familiar healthcare settings.

Patients may receive medication management during routine medical appointments. Providers can also screen for depression, anxiety, and other behavioral health concerns.

Regular appointments also enable healthcare professionals to monitor progress, adjust medications, and address evolving health needs.

Under the Consolidated Appropriations Act of 2023, federal authorities eliminated the separate DATA waiver requirement for prescribing buprenorphine to treat opioid use disorder. This change expanded opportunities for appropriately authorized clinicians to provide treatment in primary care settings.

Consequently, more patients can begin treatment without navigating multiple healthcare systems.

Combining Buprenorphine Treatment With Behavioral Health Support

Medication addresses the physical symptoms of opioid use disorder. However, many patients also benefit from counseling, mental health treatment, and practical recovery support services.

For example, behavioral health screening can identify co-occurring conditions, including depression, anxiety, and trauma-related disorders. Meanwhile, outpatient services help patients develop coping skills and strengthen their recovery strategies.

Importantly, counseling should be available without becoming a requirement for receiving buprenorphine. Buprenorphine treatment in primary care supports this patient-centered approach by connecting medication management with broader healthcare services.

Rather than focusing exclusively on opioid use, integrated treatment addresses the physical, emotional, and social challenges that can affect recovery.

How Tarzana Treatment Centers Integrates MAT and Primary Care

At Tarzana Treatment Centers (TTC), Medications for Addiction Treatment (MAT) are an important component of comprehensive substance use disorder care.

As TTC explains on its Medications for Addiction Treatment (MAT Services) page:

“TTC welcomes patients seeking Medications for Addiction Treatment as part of their recovery. Our goal as a nonprofit organization has been to make integrated treatment options available and affordable to patients.”

TTC further explains that its integrated care model makes mental health treatment and primary medical care available to patients receiving substance use disorder services.

This commitment supports buprenorphine treatment in primary care as part of a broader continuum of addiction treatment.

TTC offers MAT services across multiple levels of care, including outpatient programs, opioid treatment programs, and primary care-based services.

Treatment options include buprenorphine, methadone, naltrexone, and other FDA-approved medications.

Furthermore, TTC combines medication management with behavioral health services, counseling, case management, and medical monitoring.

For individuals seeking treatment in Los Angeles County and surrounding Southern California communities, these services provide coordinated care within an established healthcare system.

Frequently Asked Questions About Buprenorphine Treatment in Primary Care

What is buprenorphine treatment in primary care?

Buprenorphine treatment in primary care enables appropriately authorized healthcare providers to prescribe and manage medication for opioid use disorder in a general medical setting. This approach can reduce barriers to treatment and improve access to ongoing care.

How does buprenorphine help with opioid addiction?

Buprenorphine reduces opioid cravings and withdrawal symptoms. Research also shows that buprenorphine treatment lowers the risk of opioid-related overdose and improves treatment retention.

Can patients receive buprenorphine without counseling?

Yes. Although counseling and behavioral health services can strengthen recovery, patients do not need to participate in counseling to receive buprenorphine.

How long does buprenorphine treatment last?

Treatment duration varies based on individual needs. Some patients benefit from long-term maintenance treatment. Healthcare providers collaborate with patients to determine an appropriate treatment plan.

Does Tarzana Treatment Centers provide buprenorphine treatment?

Yes. TTC offers buprenorphine through its Medications for Addiction Treatment (MAT) programs, including maintenance treatment and primary care-based MAT services.

Expanding Access to Opioid Use Disorder Treatment

Opioid use disorder is a treatable medical condition. However, many individuals and families still face challenges in accessing effective treatment.

Buprenorphine treatment in primary care offers an important opportunity to close that gap.

By combining evidence-based medication, behavioral health services, and ongoing medical care, healthcare providers can help patients start treatment sooner and stay connected to recovery support.

At Tarzana Treatment Centers, this integrated approach reflects a longstanding commitment to accessible, compassionate, and comprehensive addiction treatment.

To learn more, explore TTC’s Medications for Addiction Treatment services or contact Tarzana Treatment Centers to discuss treatment options.